For decades scientists have known that age is the single biggest risk factor for brain diseases like ALS and Huntington’s disease, but they could not explain why. Now a team at the University of Cologne has identified a molecular switch that may answer that question. Their study, published in Nature Aging, shows that a protein called EPS8 builds up as we get older and drives toxic clumping of disease-related proteins, offering a fresh target for future therapies and a new way to understand what happens to the aging brain.
Scientists Discover Aging’s Hidden Trigger: The EPS8 Breakthrough
Researchers at the CECAD Cluster of Excellence for Aging Research, led by Professor Dr. David Vilchez with first author Dr. Seda Koyuncu, asked a simple but profound question: which age-related molecular changes actually cause neurodegeneration?
Using the nematode worm Caenorhabditis elegans, a classic model for aging research, they zeroed in on EPS8, a protein that accumulates with age. Previous work had already shown EPS8 shortens lifespan in worms. The new study, titled The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation, revealed the mechanism in detail.
- Accumulation: With age, EPS8 loses a chemical tag called ubiquitin. Without that tag, the cell’s recycling system (the proteasome) cannot degrade EPS8, so it builds up.
- Hyperactivation: Excess EPS8 acts as a switch for RAC proteins, swapping GDP for GTP to turn RAC on. The result is hyperactive RAC signaling across tissues.
- Downstream damage: Hyperactive EPS8 and RAC drive excessive actin polymerization that destabilizes the cytoskeleton and hyperactivates the stress kinase JNK, both of which shorten lifespan.
- Protein clumping: In worm models of Huntington’s disease and ALS, this pathway promoted pathological aggregation of polyglutamine repeats and mutant FUS and TDP-43 proteins, leading to neurodegeneration and loss of neuronal function.
Crucially, the effect was reversible. Knocking down eps-8 or its RAC counterparts prevented aggregation and preserved neuronal function during aging. The team also identified an upstream regulator, the deubiquitinating enzyme USP4, which strips ubiquitin from EPS8 and helps it accumulate. Reducing USP4 restored proper degradation, extended longevity, and blocked disease-related changes.
The researchers then tested whether the findings translate to humans. In human cell models of Huntington’s disease and ALS, inhibiting EPS8 signaling similarly reduced protein aggregation and neurodegeneration. Because EPS8 and RAC components are conserved from worms to humans, the pathway represents a plausible therapeutic target. The work was published on September 3, 2025, in Nature Aging according to the University of Cologne announcement and has only recently circulated widely through science aggregators.
As first author Dr. Seda Koyuncu noted, age has long been recognized as the major common risk factor for different neurodegenerative diseases, but exactly how age-related changes contribute has remained largely unknown. This study helps fill part of that puzzle.
What Happens to Your Aging Brain? The 5 Stages Explained
The aging brain does not decline all at once. Researchers often describe changes across decades, with distinct structural, chemical, and cognitive shifts. Understanding these stages helps separate normal aging from disease.
1. Young adulthood (20s to 30s): Peak performance
Processing speed, reasoning, and memory formation are at their peak. Vocabulary and procedural memory (skills like riding a bike) are strong and continue to improve for years.
2. Early midlife (30s to 40s): Subtle shifts begin
Brain volume begins to decline at roughly 5 percent per decade after age 40, according to the review Ageing and the brain published in the Postgraduate Medical Journal. Myelin, the fatty sheath that insulates nerve fibers and speeds communication, begins to deteriorate around the same time, even in healthy aging.
3. Midlife (40s to 50s): Structural remodeling
The prefrontal cortex, striatum, cerebellum, and hippocampus show the most volume loss, while the occipital cortex is least affected. The brain compensates by recruiting both hemispheres more symmetrically during memory tasks, a phenomenon called HAROLD (hemispheric asymmetry reduction in older adults).
4. Late midlife (50s to 70s): Cognitive trade-offs
Episodic memory (recalling specific events) declines from middle age, especially for recall rather than recognition. Semantic memory (facts and knowledge) often increases into the young-elderly years before declining in the very old. Attention and the ability to divide attention diminish, as does production of dopamine, which drops about 10 percent per decade from early adulthood.
5. Later life (70s and beyond): Reserve and vulnerability
Incidence of white matter lesions, stroke, and dementia rises sharply. About 20 percent of 80-year-olds and about 40 percent of 90-year-olds live with dementia. Yet cognitive reserve, built through education, occupational complexity, and mental engagement, allows many people to remain cognitively intact even at 100 years old.
Common symptoms of an aging brain that reflect normal change include:
- Slower recall for names and words, with preserved recognition
- Needing more time to learn new information or multitask
- Mild decrease in processing speed, while vocabulary and learned skills remain stable
- Occasional misplacement of items, with eventual retrieval
These patterns differ from disease-related decline, where deficits interfere with daily life, a distinction explored in detail later.
Why Does Aging Trigger Brain Disease? The Protein Clumping Connection
Aging and brain disease were long linked by correlation. The EPS8 study provides a mechanistic bridge. Instead of aging simply wearing the brain down, a specific aging factor actively drives pathology.
In healthy cells, protein homeostasis, or proteostasis, keeps production, folding, dispatch, and recycling in balance. Think of it as a factory line that builds proteins, folds them into correct shapes, and recycles defective ones. With age, EPS8 accumulation jams the line by hyperactivating RAC signaling, which encourages disease proteins to misfold and clump into toxic aggregates. These aggregates are defining features of Huntington’s disease, ALS, and other neurodegenerative disorders.
Traditional explanations focused on accumulated damage, oxidative stress, vascular factors, and amyloid or tau buildup in Alzheimer’s disease. The new pathway adds an upstream driver: loss of ubiquitination by USP4 leads to EPS8 buildup, which leads to RAC hyperactivation, which leads to actin and JNK dysregulation, which leads to aggregation. Blocking any link in the chain, particularly EPS8 or RAC, breaks the cascade in both worm and human cell models.
What causes most dementia? Alzheimer’s disease accounts for 40 to 70 percent of dementia cases, with vascular dementia comprising 15 to 30 percent. Postmortem studies show that 77 percent of vascular dementia cases also have Alzheimer’s pathology, suggesting overlapping mechanisms rather than entirely separate diseases. Protein aggregation sits at the center of this overlap, which is why a conserved aging switch like EPS8 could influence multiple conditions at once.
The findings also help explain why treatments aimed only at the end products, such as clearing aggregates after they form, have struggled.
Targeting an aging regulator that drives aggregation in the first place may offer a more upstream strategy.
At What Age Does Cognitive Decline Actually Begin?
One of the most common PAA questions is at what age the brain declines the fastest and whether decline after 70 is normal.
Research shows decline is gradual, not cliff-like:
- Episodic memory begins to decline from middle age, with measurable changes in the 40s and 50s.
- Processing speed and reasoning start to soften in the 50s, while crystallized abilities like vocabulary continue to improve into the 60s.
- Mild cognitive impairment affects about 16 percent of people over 70, while dementia affects about 14 percent in the same age group. Of those with mild cognitive impairment, only 15 to 20 percent eventually progress to dementia.
- The ages around 50 and 70 are often inflection points in longitudinal studies, not because a switch flips, but because accumulated structural changes, including brain volume loss and white matter changes, begin to have a functional impact if reserve is low.
Is cognitive decline at 70 normal? Some slowing is expected. Forgetting where you parked is typical; forgetting that you drove is not. Normal aging forgetfulness is occasional, inconsistently impairs daily tasks, and improves with cues. Dementia-related forgetfulness is persistent, worsens over months, affects daily functioning, and is often accompanied by other signs such as difficulty finding words, getting lost in familiar places, or personality changes.
| Feature | Normal Aging Brain | Early Disease Signal |
|---|---|---|
| Memory lapse frequency | Occasional, occasional word-finding pauses | Frequent, worsening over weeks to months |
| Cueing helps? | Yes, recall improves with hints | Often no improvement despite cues |
| Daily life impact | Minimal, tasks take longer | Interferes with bills, cooking, navigation, work |
| Other domains | Stable reasoning and personality | Changes in language, mood, motivation, or spatial awareness |
| Brain structure | Gradual volume loss, about 5% per decade after 40 | Accelerated atrophy, especially hippocampus and cortex, plus protein aggregates |
| Possible contributor identified by new research | Low EPS8 and balanced RAC signaling | High EPS8, hyperactive RAC and JNK, actin destabilization |
If changes feel new, progressive, or disruptive, early evaluation matters. Simple screening tools like the MMSE or MoCA can detect impairment, followed by more specialized spatial and memory tests that research shows are more sensitive to early decline.
Can You Slow Down or Reverse Brain Aging?
The second most asked cluster is whether brain aging can be slowed or reversed. While no pill reverses aging outright, evidence supports strategies that slow the rate and build resilience. The EPS8 work itself hints at a future approach: reducing EPS8 or inhibiting USP4 attenuated aging effects and extended lifespan in worms, and knockout of Eps8 in mice also extends lifespan. Human therapies targeting this axis are not yet available, but the lifespan data from two species suggests the pathway influences biological aging beyond a single disease.
Until such therapies arrive, these science-backed levers show consistent benefit:
- Move regularly: Aerobic exercise improves cerebral blood flow, supports neurogenesis, and is linked to better memory. The brain-boosting benefits of exercise are among the most reproducible findings in aging research.
- Protect your heart to protect your brain: Midlife vascular risk factors such as hypertension, smoking, and diabetes increase later dementia risk. Even monthly fish consumption has been associated with lower stroke risk in some cohorts.
- Keep learning: Education and cognitively demanding occupations build cognitive reserve. New skills, language learning, and complex hobbies create redundant networks that delay symptom onset.
- Sleep and stress management: Chronic stress raises cortisol and disrupts memory consolidation. Consistent sleep allows clearance of metabolic waste, including aggregation-prone proteins.
- Stay socially and sensorially engaged: Social isolation has been linked to accelerated brain aging. In a University of Nottingham study of about 1,000 adults scanned before and after the pandemic, brain aging accelerated even in people never infected, most pronounced in older adults, men, and those from disadvantaged backgrounds.
- Manage hearing and vision: Unaddressed sensory loss increases cognitive load and isolation, both risk factors for faster decline.
- Eat for vascular and brain health: Patterns rich in leafy greens, berries, nuts, whole grains, and omega-3 sources are associated with slower decline. No single superfood reverses aging, despite frequent searches for three superfoods for your brain.
Is brain aging reversible? At the cellular level, interventions that improve proteostasis, such as reducing EPS8 signaling in animal models, have prevented age-related changes and extended longevity. In humans, reversal is better framed as improving the brain age gap. Studies show people in their 80s can have neuroimaging-estimated brain ages resembling someone in their 70s when vascular, lifestyle, and cognitive factors are optimal. The goal is not to turn back the clock to 25 but to keep biological brain age younger than chronological age.
Aging Brain vs. Dementia: How to Tell the Difference
Searches for aging brain vs. dementia reflect real confusion about what counts as normal. Aging brain changes include slower retrieval, reduced divided attention, and gradual atrophy driven mainly by synaptic loss rather than massive cell death. Dementia, including Alzheimer’s disease, involves significant neuronal and synaptic loss, with specific protein pathologies that disrupt networks critical for memory and daily function.
Key differences to watch:
- Course: Normal aging is slow, variable, and often plateaus. Dementia is progressive over months to years without improvement.
- Pattern: Aging affects recall and speed. Dementia often impairs learning new information, orientation, and executive function together.
- Cueing: Hints help typical age-related lapses. In dementia, cues often do not restore the memory.
- Function: Dementia interferes with managing finances, medications, and familiar routes.
- Personality: Early personality changes, apathy, irritability, or loss of initiative can be first signs of dementia, not just memory loss.
How much forgetfulness is expected with aging? Occasional forgetfulness, such as misplacing keys but retracing steps successfully, is expected. Frequent forgetting of recent events, repeating the same questions, or needing reminders for routine tasks is not expected and warrants assessment. Because about 15 to 20 percent of mild cognitive impairment progresses to dementia, early detection creates a window for intervention, safety planning, and participation in clinical trials that increasingly use sensitive spatial navigation tests rather than relying on pen-and-paper screening alone.
For a deeper look at detection advances, see how researchers are developing new ways to scan the brain for dementia caused by disease, which complement molecular insights like the EPS8 pathway by improving early diagnosis.
Frequently Asked Questions
What are the symptoms of an aging brain?
Typical symptoms include slower processing, occasional difficulty recalling names or words, reduced multitasking ability, and needing more time to learn new information. Procedural memory and vocabulary often stay strong. These shifts are gradual and do not usually prevent daily activities.
What are the three superfoods for your brain?
No three foods alone prevent brain aging, despite popular searches. Evidence most strongly supports an overall dietary pattern rich in leafy greens, berries and other colorful fruits, nuts, fatty fish, and whole grains, while limiting ultra-processed foods, excess alcohol, and added sugars that harm vascular health.
What are the 5 stages of brain aging?
Researchers describe a continuum rather than strict stages: young adult peak in the 20s to 30s, subtle shifts in the 30s to 40s with early myelin changes, structural remodeling in the 40s to 50s, cognitive trade-offs in the 50s to 70s, and later-life vulnerability balanced by cognitive reserve built through education and engagement.
At what age does cognitive decline start?
Some aspects, like processing speed and episodic recall, show measurable softening from the 40s and 50s. However, major daily-life impairment is not normal at any age. Mild cognitive impairment affects about 16 percent of people over 70, while dementia affects about 14 percent, meaning most older adults do not have dementia.
Is cognitive decline at 70 normal?
Some slowing is expected, but progressive decline that interferes with daily tasks is not. If memory lapses become frequent, worsen despite cues, or are accompanied by language or personality changes, seek clinical evaluation rather than assuming it is just age.
What are early signs of personality changes in people with dementia?
Common early changes include apathy or loss of initiative, increased irritability, social withdrawal, reduced empathy, or anxiety in familiar situations. These reflect changes in brain networks that regulate motivation and emotion, not simply mood.
What causes 70 percent of dementia?
No single cause accounts for 70 percent. Alzheimer’s disease causes 40 to 70 percent of cases, depending on population and criteria. Vascular contributions overlap heavily, with many cases showing mixed pathology. The new EPS8 research suggests that age-driven protein aggregation pathways may underlie multiple dementia types.
How much forgetfulness is expected with aging?
Occasional forgetfulness that resolves with cues and does not disrupt daily life is expected. Forgetting recent conversations frequently, repeating questions, or getting lost on familiar routes is not expected and should be evaluated.
What are rare brain diseases that can lead to death?
Rare fatal neurodegenerative conditions include Creutzfeldt-Jakob disease, a prion disease, and other rapidly progressive syndromes. ALS and Huntington’s disease are serious neurodegenerative diseases with high mortality that have been directly studied in the EPS8 work.
What are the symptoms of brain diseases in general?
Symptoms vary by condition but can include memory loss, language difficulty, muscle weakness or twitching in ALS, involuntary movements in Huntington’s, seizures, vision changes, headaches, or personality changes. Any new, persistent neurological symptom deserves prompt medical attention.
The New Frontier for the Aging Brain
The aging brain is not simply wearing out. The discovery that an aging factor, EPS8, and its regulator USP4 can drive RAC hyperactivation and toxic protein clumping provides the clearest mechanistic link yet between getting older and developing diseases like Huntington’s and ALS. Because reducing EPS8 prevented aggregation in both worms and human cells and extended lifespan in animal models, the pathway offers a compelling direction for therapies that aim at aging itself rather than just its late symptoms.
For now, the most powerful tools remain the familiar ones: protect vascular health, stay physically and mentally active, prioritize sleep, manage stress, and seek early evaluation for progressive changes. Molecular insights like EPS8 ensure that future tools may be more precise, targeting the hidden trigger that makes time the brain’s greatest risk factor.
